Workflow
威高血净(603014.SH):向激励对象授予636万股限制性股票

Core Viewpoint - Weigao Blood Products (603014.SH) announced the approval of its 2025 restricted stock incentive plan, granting 6.36 million shares at a price of 19.77 yuan per share to 120 eligible recipients on September 16, 2025 [1] Summary by Relevant Categories Incentive Plan Details - The board's compensation and assessment committee confirmed that the granting conditions for the incentive plan have been met [1] - The grant date for the restricted stock incentive plan is set for September 16, 2025 [1] - A total of 6.36 million shares will be granted to 120 eligible recipients [1] Financial Aspects - The grant price for the restricted stock is established at 19.77 yuan per share [1]